Uncategorised - European Medical Journal

Efruxifermin Improves Fibrosis in Long-Term MASH Study

In this double-blind, placebo-controlled trial, 181 participants were randomised to receive weekly injections of either 28 mg or 50 mg of efruxifermin or a placebo.

Bridging the Catatonia Knowledge Gap in Clinics

Catatonia remains a misunderstood neuropsychiatric condition, and a new evidence-based review challenges ten prevailing myths that may delay diagnosis and compromise patient outcomes.

Phase III Data Examines New Regimen in BRAF-Mutant Colorectal Cancer: ASCO 2025

Results from an international Phase III clinical trial presented at the 2025 ASCO Annual Meeting evaluate a treatment regimen combining encorafenib and cetuximab with mFOLFOX6 chemotherapy in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC).

Syphilis and Drug-Resistant Gonorrhoea on the Rise

The UKHSA has released its annual STI data, with continuing concern over rising syphilis and drug-resistant gonorrhoea.

Global Rise in Skin Cancer Among Older Adults

A new global observational study has revealed a continued rise in skin cancer burden among older populations, particularly in high-income countries.

Radiotherapy After Prostate Surgery Causes Minimal Side Effects

This clinical trial evaluated the safety of stereotactic body radiotherapy to the prostate bed following radical prostatectomy.

Albuterol–Budesonide Combo Inhaler To Lower Asthma Risk

A large randomized trial has found that as-needed use of a fixed-dose combination of albuterol and budesonide significantly reduces the risk of severe asthma exacerbations compared to albuterol alone in patients with mild asthma.

Uncovering Who Carries Salmonella Long-Term

A new study has identified key risk factors that may predispose individuals to long-term shedding (LTS) of non-typhoidal Salmonella (NTS), offering insights into why certain patients remain contagious weeks after initial infection.

PET/CT Refines Biopsy Strategy for Suspected Lung Cancer

New findings support the integration of PET/CT prior to biopsy in patients with intermediate-to-high-risk lung nodules.

Breast MRI Efficiency Boosted by AI Without Compromising Diagnosis

AI-guided breast MRI could halve scan times without missing cancers, offering new efficiency for screening programmes.